NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 4, 2025 $8.35 +5.56% $7.88 X 94.04% 0
Mar 4, 2025 $8.18 +3.47% $7.88 X 96.13% 0
Mar 4, 2025 $9.42 +4.90% $7.88 X 80.46% 0
Mar 3, 2025 $9.40 +4.65% $7.91 X 81.19% 0
Mar 3, 2025 $9.24 +2.89% $7.91 X 83.20% 0
Mar 3, 2025 Bullish $7.91 X 0
Skagitqg Skagitqg Merchant
Mar 3, 2025 Bearish $7.91 V 1
Feb 27, 2025 $8.91 +5.20% $8.60 V 96.39% 1
Feb 27, 2025 $8.74 +3.23% $8.60 V 98.33% 1
Feb 27, 2025 $9.00 +6.26% $8.60 V 95.35% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE